Cargando…
Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
Around a quarter of people who experience a first episode of psychosis (FEP) will develop treatment-resistant schizophrenia (TRS), but there are currently no established clinically useful methods to predict this from baseline. We aimed to explore the predictive potential for clozapine use as a proxy...
Autores principales: | Osimo, Emanuele F., Perry, Benjamin I., Mallikarjun, Pavan, Pritchard, Megan, Lewis, Jonathan, Katunda, Asia, Murray, Graham K., Perez, Jesus, Jones, Peter B., Cardinal, Rudolf N., Howes, Oliver D., Upthegrove, Rachel, Khandaker, Golam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614410/ https://www.ncbi.nlm.nih.gov/pubmed/37034013 http://dx.doi.org/10.1038/s44220-022-00001-z |
Ejemplares similares
-
Predicting treatment resistance in people with a first-episode of psychosis using commonly recorded clinical information
por: Osimo, E.F., et al.
Publicado: (2022) -
Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis
por: Perry, Benjamin I, et al.
Publicado: (2021) -
Inflammatory and cardiometabolic markers at presentation with first episode psychosis and long-term clinical outcomes: A longitudinal study using electronic health records
por: Osimo, Emanuele F., et al.
Publicado: (2021) -
Clozapine treatment and risk of COVID-19
por: Osimo, Emanuele F., et al.
Publicado: (2022) -
Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study
por: Osimo, Emanuele F., et al.
Publicado: (2018)